As of 2025-01-20, the Relative Valuation of Veracyte Inc (VCYT) is (2.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 40.58 USD, the upside of Veracyte Inc based on Relative Valuation is -106.4%.
The range of the Relative Valuation is (2.16) - (2.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 34.6x | 25.4x |
| Forward P/E multiples | 18.1x - 18.6x | 18.4x |
| Fair Price | (2.16) - (2.22) | (2.61) |
| Upside | -105.3% - -105.5% | -106.4% |
| Date | P/E |
| 2025-01-17 | -339.33 |
| 2025-01-16 | -343.68 |
| 2025-01-15 | -348.87 |
| 2025-01-14 | -343.35 |
| 2025-01-13 | -357.73 |
| 2025-01-10 | -347.36 |
| 2025-01-08 | -366.09 |
| 2025-01-07 | -355.31 |
| 2025-01-06 | -363.00 |
| 2025-01-03 | -350.46 |
| 2025-01-02 | -338.16 |
| 2024-12-31 | -331.14 |
| 2024-12-30 | -334.48 |
| 2024-12-27 | -335.49 |
| 2024-12-26 | -342.43 |
| 2024-12-24 | -344.35 |
| 2024-12-23 | -342.76 |
| 2024-12-20 | -341.93 |
| 2024-12-19 | -326.71 |
| 2024-12-18 | -330.55 |
| 2024-12-17 | -353.22 |
| 2024-12-16 | -362.33 |
| 2024-12-13 | -361.41 |
| 2024-12-12 | -371.28 |
| 2024-12-11 | -363.84 |
| 2024-12-10 | -359.40 |
| 2024-12-09 | -357.56 |
| 2024-12-06 | -369.02 |
| 2024-12-05 | -358.23 |
| 2024-12-04 | -368.69 |
| 2024-12-03 | -365.09 |
| 2024-12-02 | -368.94 |
| 2024-11-29 | -359.15 |
| 2024-11-27 | -358.65 |
| 2024-11-26 | -358.23 |
| 2024-11-25 | -343.68 |
| 2024-11-22 | -331.06 |
| 2024-11-21 | -325.62 |
| 2024-11-20 | -327.79 |
| 2024-11-19 | -327.38 |
| 2024-11-18 | -306.97 |
| 2024-11-15 | -300.53 |
| 2024-11-14 | -309.73 |
| 2024-11-13 | -330.55 |
| 2024-11-12 | -319.77 |
| 2024-11-11 | -325.20 |
| 2024-11-08 | -305.05 |
| 2024-11-07 | -312.24 |
| 2024-11-06 | -305.97 |
| 2024-11-05 | -300.45 |